Office of the Director, National Institutes of Health; Office of Biotechnology Activity; Recombinant DNA Research; Notice of a Meeting of an NIH Blue Ribbon Panel, 54841-54842 [E8-22313]
Download as PDF
Federal Register / Vol. 73, No. 185 / Tuesday, September 23, 2008 / Notices
54841
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Name of Committee: Board of Scientific
Counselors, National Institute of
Neurological Disorders and Stroke.
Date: October 5–7, 2008.
Time: October 5, 2008, 7 p.m. to 10 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Diplomat/Ambassador Room,
Bethesda, MD 20814.
Time: October 6, 2008, 8:30 a.m. to 2:10
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Room A, Rockville,
MD 20852.
Time: October 6, 2008, 3:10 p.m. to 8:10
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Diplomat/Ambassador Room,
Bethesda, MD 20814.
Time: October 7, 2008, 8:30 a.m. to 12 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Diplomat/Ambassador Room,
Bethesda, MD 20814.
Contact Person: Alan P. Koretsky, PhD,
Scientific Director, Division of Intramural
Research, National Institute of Neurological
Disorders & Stroke, NIH, 35 Convent Drive,
Room 6a 908, Bethesda, MD 20892, 301–435–
2232, koretskya@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
jlentini on PROD1PC65 with NOTICES
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
National Cancer Institute; Notice of
Closed Meeting
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2) notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections 552b(c)
(4) and 552b(c) (6), Title 5 U.S.C., as
amended. The purpose of this meeting
is to evaluate requests for preclinical
development resources for potential
new therapeutics for the treatment of
cancer. The outcome of the evaluation
will be a decision whether NCI should
support request(s) and make available
contract resources for development of
the potential therapeutic to improve the
treatment of various forms of cancer.
The research proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material and
personal information concerning
individuals associated with the
proposed research projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Dated: September 17, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–22309 Filed 9–22–08; 8:45 am]
BILLING CODE 4140–01–P
Name of Committee: National Cancer
Institute Special Emphasis Panel; Rapid
Access to Intervention Development.
Date: November 5–6, 2008.
Time: 1 p.m.–5 p.m.
Agenda: To evaluate the Rapid Access to
Intervention Development Portfolio.
Place: National Institutes of Health,
Executive Plaza North, Conference Room H,
6130 Executive Boulevard, Rockville, MD
20852.
Contact Person: Phyllis G. Bryant,
Executive Secretary, Program Analyst,
Developmental Therapeutics Program,
National Cancer Institute, NIH, 6130
Executive Boulevard, Rm. 8022, Bethesda,
MD 20892, (301) 496–8720, pb45q@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: September 17, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–22316 Filed 9–22–08; 8:45 am]
BILLING CODE 4140–01–P
VerDate Aug<31>2005
16:54 Sep 22, 2008
Jkt 214001
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
Name of Committee: National Institute on
Aging Initial Review Group; Neuroscience of
Aging Review Committee.
Date: October 14–15, 2008.
Time: 4 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: William Cruce, PhD,
Scientific Review Administrator, National
Institute on Aging, Scientific Review Office,
Gateway Building 2C–212, 7201 Wisconsin
Ave., Bethesda, MD 20814, 301–402–7704,
crucew@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: September 15, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–22057 Filed 9–22–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Office of
Biotechnology Activity; Recombinant
DNA Research; Notice of a Meeting of
an NIH Blue Ribbon Panel
There will be a meeting of the NIH
Blue Ribbon Panel to advise on the Risk
Assessment of the National Emerging
Infectious Diseases Laboratories
(NEIDL). The meeting will be held on
Tuesday, October 14, 2008, at the
Roxbury Center for the Arts, Hibernian
Hall, 184 Dudley Street, Roxbury, MA
E:\FR\FM\23SEN1.SGM
23SEN1
54842
Federal Register / Vol. 73, No. 185 / Tuesday, September 23, 2008 / Notices
02119 from approximately 6:30 p.m. to
9:30 p.m.
Discussions will focus on principles
and strategies for effective community
engagement. There will also be time
allotted on the agenda for public
comment.
Sign up for public comment will
begin at approximately 5:30 p.m. on
October 14, 2008. In the event that time
does not allow for all those interested to
present oral comments, anyone may file
written comments using the address
below.
For further information concerning
this meeting contact Ms. Laurie
Lewallen, Advisory Committee
Coordinator, Office of Biotechnology
Activities, Office of the Director,
National Institutes of Health, Mail Stop
Code 7985, Bethesda, MD 20892–7985,
telephone 301–496–9838, e-mail
lewallla@od.nih.gov. Background
information may be obtained by
contacting NIH OBA by e-mail
oba@od.nih.gov.
Dated: September 16, 2008.
Kelly R. Fennington,
Special Assistant to the Director, Office of
Biotechnology Activities, National Institutes
of Health.
[FR Doc. E8–22313 Filed 9–22–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[USCG–2008–0961]
Information Collection Request to
Office of Management and Budget;
OMB Control Number: 1625–0073
Coast Guard, DHS.
Sixty-day notice requesting
comments.
AGENCY:
(1) Online: https://
www.regulations.gov.
(2) Mail: Docket Management Facility
(DMF) (M–30), U.S. Department of
Transportation (DOT), West Building
Ground Floor, Room W12–140, 1200
New Jersey Avenue, SE., Washington,
DC 20590–0001.
(3) Hand deliver between 9 a.m. and
5 p.m., Monday through Friday, except
Federal holidays. The telephone number
is 202–366–9329.
(4) Fax: 202–493–2251.
The DMF maintains the public docket
for this notice. Comments and material
received from the public, as well as
documents mentioned in this notice as
being available in the docket, will
become part of this docket and will be
available for inspection or copying at
room W12–140 on the West Building
Ground Floor, 1200 New Jersey Avenue,
SE., Washington, DC, between 9 a.m.
and 5 p.m., Monday through Friday,
except Federal holidays. You may also
find this docket on the Internet at
https://www.regulations.gov.
A copy of the complete ICR is
available through this docket on the
Internet at https://www.regulations.gov.
Additionally, copies are available from
Commandant (CG–611), U.S. Coast
Guard Headquarters, (Attn: Mr. Arthur
Requina), 2100 2nd Street, SW.,
Washington, DC 20593–0001. The
telephone number is 202–475–3523.
FOR FURTHER INFORMATION CONTACT: Mr.
Arthur Requina, Office of Information
Management, telephone 202–475–3523,
or fax 202–475–3929, for questions on
these documents. Contact Ms. Renee V.
Wright, Program Manager, Docket
Operations, 202–366–9826, for
questions on the docket.
SUPPLEMENTARY INFORMATION:
ACTION:
Public Participation and Request for
Comments.
In compliance with the
Paperwork Reduction Act of 1995, the
U.S. Coast Guard intends to submit an
Information Collection Request (ICR)
and Analysis to the Office of
Management and Budget (OMB)
requesting an extension of its approval
for the following collection of
information: 1625–0073, Alteration of
Unreasonable Obstructive Bridges.
Before submitting this ICR to OMB, the
Coast Guard is inviting comments as
described below.
DATES: Comments must reach the Coast
Guard on or before November 24, 2008.
ADDRESSES: To avoid duplicate
submissions to the docket [USCG–2008–
0961], please use only one of the
following means:
The Coast Guard invites comments on
whether this information collection
request should be granted based on it
being necessary for the proper
performance of Departmental functions.
In particular, the Coast Guard would
appreciate comments addressing: (1)
The practical utility of the collections;
(2) the accuracy of the estimated burden
of the collections; (3) ways to enhance
the quality, utility, and clarity of
information subject to the collections;
and (4) ways to minimize the burden of
collections on respondents, including
the use of automated collection
techniques or other forms of information
technology.
We encourage you to respond to this
request by submitting comments and
related materials. We will post all
jlentini on PROD1PC65 with NOTICES
SUMMARY:
VerDate Aug<31>2005
16:54 Sep 22, 2008
Jkt 214001
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
comments received, without change, to
https://www.regulations.gov. They will
include any personal information you
provide. We have an agreement with
DOT to use their DMF. Please see the
paragraph on DOT’s ‘‘Privacy Act
Policy’’ below.
Submitting comments: If you submit a
comment, please include the docket
number [USCG–2008–0961], indicate
the specific section of the document to
which each comment applies, providing
a reason for each comment. We
recommend you include your name,
mailing address, an e-mail address, or
other contact information in the body of
your document so that we can contact
you if we have questions regarding your
submission. You may submit your
comments and material by electronic
means, mail, fax, or delivery to the DMF
at the address under ADDRESSES; but
please submit them by only one means.
If you submit them by mail or delivery,
submit them in an unbound format, no
larger than 81⁄2 by 11 inches, suitable for
copying and electronic filing. If you
submit them by mail and would like to
know that they reached the Facility,
please enclose a stamped, self-addressed
postcard or envelope. We will consider
all comments and material received
during the comment period. We may
change the documents supporting this
collection of information or even the
underlying requirements in view of
them.
Viewing comments and documents:
Go to https://www.regulations.gov to
view documents mentioned in this
notice as being available in the docket.
Enter the docket number for this notice
[USCG–2008–0961] in the Search box,
and click ‘‘Go >>.’’ You may also visit
the DMF in room W12–140 on the West
Building Ground Floor, 1200 New Jersey
Avenue, SE., Washington, DC, between
9 a.m. and 5 p.m., Monday through
Friday, except Federal holidays.
Privacy Act: Anyone can search the
electronic form of all comments
received in dockets by the name of the
individual submitting the comment (or
signing the comment, if submitted on
behalf of an association, business, labor
union, etc.). You may review the
Privacy Act statement regarding our
public dockets in the January 17, 2008
issue of the Federal Register (73 FR
3316).
Information Collection Request.
Title: Alteration of Unreasonable
Obstructive Bridges.
OMB Control Number: 1625–0073.
Summary: This collection of
information is used to determine if a
bridge is unreasonably obstructive.
E:\FR\FM\23SEN1.SGM
23SEN1
Agencies
[Federal Register Volume 73, Number 185 (Tuesday, September 23, 2008)]
[Notices]
[Pages 54841-54842]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-22313]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Office of
Biotechnology Activity; Recombinant DNA Research; Notice of a Meeting
of an NIH Blue Ribbon Panel
There will be a meeting of the NIH Blue Ribbon Panel to advise on
the Risk Assessment of the National Emerging Infectious Diseases
Laboratories (NEIDL). The meeting will be held on Tuesday, October 14,
2008, at the Roxbury Center for the Arts, Hibernian Hall, 184 Dudley
Street, Roxbury, MA
[[Page 54842]]
02119 from approximately 6:30 p.m. to 9:30 p.m.
Discussions will focus on principles and strategies for effective
community engagement. There will also be time allotted on the agenda
for public comment.
Sign up for public comment will begin at approximately 5:30 p.m. on
October 14, 2008. In the event that time does not allow for all those
interested to present oral comments, anyone may file written comments
using the address below.
For further information concerning this meeting contact Ms. Laurie
Lewallen, Advisory Committee Coordinator, Office of Biotechnology
Activities, Office of the Director, National Institutes of Health, Mail
Stop Code 7985, Bethesda, MD 20892-7985, telephone 301-496-9838, e-mail
lewallla@od.nih.gov. Background information may be obtained by
contacting NIH OBA by e-mail oba@od.nih.gov.
Dated: September 16, 2008.
Kelly R. Fennington,
Special Assistant to the Director, Office of Biotechnology Activities,
National Institutes of Health.
[FR Doc. E8-22313 Filed 9-22-08; 8:45 am]
BILLING CODE 4140-01-P